Healthy Aging and Memory Study
This study has been completed.
Sponsor:
Information provided by:
National Institute on Aging (NIA)
ClinicalTrials.gov Identifier:
NCT00034567
First received: April 30, 2002
Last updated: September 14, 2007
Last verified: September 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This project will focus on the development and testing of efficient, cost effective measures that are specifically designed for use in Alzheimer's Disease (AD) primary prevention trials.
| Condition |
|---|
|
Alzheimer Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Prospective |
| Official Title: | Alzheimer's Disease Prevention Instrument Protocol |
Resource links provided by NLM:
Further study details as provided by National Institute on Aging (NIA):
| Estimated Enrollment: | 650 |
This project will focus on the development and testing of efficient, cost effective measures that are specifically designed for use in AD primary prevention trials. The new or improved measures that have been developed will then be evaluated in 650 nondemented subjects enrolled in a simulated Alzheimer's disease prevention trial. Once enrolled, subjects will be followed for four years with annual clinical evaluations and interim six-month phone calls.
Eligibility| Ages Eligible for Study: | 75 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- 75 years or older.
- Fluent in English or Spanish.
- Stable medical condition for four weeks prior to screening visit.
- Stable medications for four weeks prior to screening visit.
- Either cognitively normal, or mild cognitive impairment. If MCI, the subject's CDR at screening have a global score of 0.5.
- mMMSE score greater than 88 for subjects with at least 8 years education, or greater than 80 for subjects with less than 8 years education, and FCSRT total free plus cued recall score greater than 44 with 3 learning trials.
- Willing to participate in four to five year follow-up study.
- Willing to identify person who can serve as informant.
- At least six years education or work history sufficient to exclude mental retardation
Exclusion Criteria:
- Meets DSM IV criteria for dementia
- History of clinically significant medical illness that would interfere with participation in trial, including active malignancy, myocardial infarction, or cerebrovascular accident within the past year
- Alcohol or substance abuse and/or active major psychiatric disorders
- Concurrent participation in a clinical drug trial
- History of mental retardation
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00034567
Show 39 Study Locations
Show 39 Study LocationsSponsors and Collaborators
Investigators
| Study Director: | Steven H. Ferris, PhD | New York University School of Medicine |
More Information
Additional Information:
Publications:
| ClinicalTrials.gov Identifier: | NCT00034567 History of Changes |
| Other Study ID Numbers: | IA0032 |
| Study First Received: | April 30, 2002 |
| Last Updated: | September 14, 2007 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute on Aging (NIA):
|
Prevention |
Additional relevant MeSH terms:
|
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on June 18, 2013